Immune checkpoint inhibitors are a form of cancer immunotherapy successfully used to treat a wide range of cancers. However, ...

USA: A matched-cohort study found that patients with lung cancer, melanoma, or kidney cancer who received PCSK9 inhibitors ...

Liver transplantation remains one of the most powerful curative options for hepatocellular carcinoma (HCC) because it removes both the tumor and the diseased liver.

100% confirmed complete radiographic and complete metabolic responses in three patients who progressed on ELI-002 7P treatment during the Phase 2 AMPLIFY-7P study and received nivolumab-based ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors—a type of immunotherapy—using ...

Colon cancer hides from the immune system via one gene. University of Calgary researchers deleted it in mice, eradicating 100 ...

Recent Publication and Growing Industry Focus on Immune-Priming Strategies Support Continued Evaluation of Gedeptin(R) as a ...

Therapy to Enhance Checkpoint Inhibitor Responses and Activate Systemic Anti-Tumor Immunity ATLANTA, GA - June 8, 2026 ...

Subcutaneous immunotherapy injections for cancer, such as immune checkpoint inhibitors, are an emerging therapy that may replace some traditional intravenous infusions. Common side effects include ...

A multinational collaboration co-led by the Garvan Institute of Medical Research, in collaboration with Rockefeller University, and Kyoto University Graduate School of Medicine, has uncovered a ...

Dr. Luc Morris, a surgeon and research lab director at MSK, was the co-senior author of a research study to predict who will benefit from immune checkpoint inhibitors, a type of immunotherapy, using ...